rs2430853
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_015295.3(SMCHD1):āc.174G>Cā(p.Ala58=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.563 in 1,489,176 control chromosomes in the GnomAD database, including 241,052 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Synonymous variant affecting the same amino acid position (i.e. A58A) has been classified as Pathogenic.
Frequency
Consequence
NM_015295.3 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMCHD1 | NM_015295.3 | c.174G>C | p.Ala58= | synonymous_variant | 1/48 | ENST00000320876.11 | NP_056110.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMCHD1 | ENST00000320876.11 | c.174G>C | p.Ala58= | synonymous_variant | 1/48 | 5 | NM_015295.3 | ENSP00000326603 | P2 | |
SMCHD1 | ENST00000688342.1 | c.174G>C | p.Ala58= | synonymous_variant | 1/47 | ENSP00000508422 | A2 | |||
SMCHD1 | ENST00000684915.1 | n.331G>C | non_coding_transcript_exon_variant | 1/14 |
Frequencies
GnomAD3 genomes AF: 0.633 AC: 96332AN: 152064Hom.: 32011 Cov.: 33
GnomAD3 exomes AF: 0.558 AC: 82317AN: 147528Hom.: 23631 AF XY: 0.557 AC XY: 46456AN XY: 83462
GnomAD4 exome AF: 0.555 AC: 741595AN: 1336994Hom.: 208989 Cov.: 46 AF XY: 0.557 AC XY: 368498AN XY: 661722
GnomAD4 genome AF: 0.634 AC: 96443AN: 152182Hom.: 32063 Cov.: 33 AF XY: 0.632 AC XY: 47043AN XY: 74388
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Dec 18, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 29, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Mar 23, 2016 | - - |
Facioscapulohumeral muscular dystrophy 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Arrhinia with choanal atresia and microphthalmia syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at